Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Antimicrob Chemother ; 70(12): 3397-400, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26349519

RESUMEN

OBJECTIVES: The objective of this study was to attain a better understanding of infectious diseases (ID) physicians' experience with MDR organism (MDRO) urinary tract infections (UTIs) by means of a survey on disease perception, diagnostic management and treatment preferences. METHODS: A nine-question survey was developed and distributed to members of the North American Emerging Infections Network (EIN) in September 2013. RESULTS: Seven hundred and fourteen out of 1461 EIN members responded to the survey (49%). The responses of 603 responders were studied. Most providers perceived an increase in the incidence of MDRO UTIs over the past 3 years (75% of adult ID responders and 63% of paediatric ID responders). One hundred and thirty-four (22%) responders prefer intravenous over oral administration of antimicrobials when both are available, 171 (28%) prefer longer durations of therapy when comparing an MDRO with a susceptible isolate of the same species and 142 (24%) order a repeat urine culture as 'proof of cure' after treating an MDRO UTI. Nevertheless, 530 (88%) responders perceived MDRO UTIs to be of similar severity as non-MDRO UTIs. Fifty-five percent of providers prescribed fosfomycin for MDRO UTI at least once; the most common prescribing pattern (among a wide spectrum of approaches) was a single dose (16%). CONCLUSIONS: Future studies on MDRO UTIs should clarify the role of resistance in patient outcomes and the comparative efficacy of different antimicrobials. Of particular interest is fosfomycin, which is unrelated to other antibiotic classes and may take a more prominent role in treating MDRO cystitis.


Asunto(s)
Antibacterianos/uso terapéutico , Actitud del Personal de Salud , Farmacorresistencia Bacteriana Múltiple , Médicos , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/tratamiento farmacológico , Manejo de Caso , Humanos , América del Norte , Encuestas y Cuestionarios
4.
Am J Infect Control ; 44(11): 1406-1407, 2016 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-27238942

RESUMEN

The optimal approach for the prevention of ventilator-associated complications (VACs) is currently unknown. A retrospective pre-post intervention analysis was conducted to assess a multifaceted educational intervention targeting the most common causes for VACs and VAC risk factors. Results indicated that the addition of this intervention to existing infection control and treatment protocols did not demonstrate a decrease in VAC occurrence or duration of mechanical ventilation.


Asunto(s)
Terapia Conductista/métodos , Educación Médica/métodos , Control de Infecciones/métodos , Neumonía Asociada al Ventilador/prevención & control , Respiración Artificial/efectos adversos , Humanos , Unidades de Cuidados Intensivos , Estudios Retrospectivos
5.
Clin Chest Med ; 36(3): 531-41, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26304289

RESUMEN

Infections with multidrug-resistant organisms (MDROs) are common in critically ill patients and are challenging to manage appropriately. Strategies that can be used in the treatment of MDRO infections in the intensive care unit (ICU) include combination therapy, adjunctive aerosolized therapy, and optimization of pharmacokinetics with higher doses or extended-infusion therapy as appropriate. Rapid diagnostic tests could assist in improving timely appropriate antimicrobial therapy for MDRO infections in the ICU.


Asunto(s)
Antiinfecciosos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple/inmunología , Unidades de Cuidados Intensivos , Cuidados Críticos , Enfermedad Crítica , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA